(1) The year ended December 31, 2023 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards ...

HOUSTON, July 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported second quarter 2025 revenue of ...

(1) Three months ended September 30, 2024 includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share ...

HOUSTON (AP) — HOUSTON (AP) — Core Laboratories Inc. (CLB) on Wednesday reported net income of $7.1 million in its fourth quarter. The Houston-based company said it had profit of 15 cents per share.

Earnings call Core Laboratories reported Q4 2025 revenue of $138.3M, up 3% sequentially and 7% YoY, with strong international service demand offsetting US softness. EPS ex items was $0.21, flat YoY.

HOUSTON, Oct. 9, 2023 /PRNewswire/ -- Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the delivery time of ...

Core Laboratories is in good financial health. At the last reporting period, the firm had $16 million of cash on hand and $180 million of long-term debt. 2022 net debt/adjusted EBITDA was elevated at ...

HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000 ...